Stay updated on Glesatinib Combo With Nivolumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page.
Latest updates to the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page
- Check7 days agoChange DetectedLocations section reorganized; a unified 'Locations' header was added and state-level site entries updated (Arizona, California, Colorado, Kentucky, Michigan, Minnesota, Nebraska, Ohio, Oregon, Pennsylvania, Tennessee, Texas, Virginia, Wisconsin).SummaryDifference1%
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page revision label was updated from v3.2.0 to v3.3.2, a minor metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check36 days agoChange DetectedThe notice about government funding and NIH Clinical Center operating status was removed, a non-significant site-wide change; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check58 days agoChange DetectedNo core study content changes are evident; the screenshots show only minor UI/layout differences on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check79 days agoChange DetectedMajor changes include a government operating status notice update and a version bump from v3.1.0 to v3.2.0. The status notice is the most important element; the version change is secondary.SummaryDifference4%
- Check86 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%
Stay in the know with updates to Glesatinib Combo With Nivolumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page.